Endothelial progenitor cells for postnatal vasculogenesis

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Asahara, Takayuki ^a,b   Kawamoto, Atsuhiko ^a  

^a RIKEN   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell transplantation; Ischemia; Neovascularization; Stem cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; BONE MARROW CELL; BRAIN CELL; CELL DEGENERATION; CELL DIFFERENTIATION; CELL POPULATION; CELL SPECIFICITY; CLINICAL FEATURE; EMBRYO; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; GENETIC IDENTIFICATION; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HINDLIMB; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL CIRCULATION; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RABBIT; REPRODUCTION; REVIEW; STEM CELL; TISSUE REGENERATION;

ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS; VERTEBRATA;

EID: 4143102425     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00330.2003     Document Type: Review

References (70)

1. Anklesaria P, Kase K, Glowacki J, Holland CA, Sakakeeny MA, Wright JA, FitzGerald TJ, Lee CY, and Greenberger JS. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 84: 7681-7685, 1987.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pasture C, Silver M, Kearney M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
4. Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R, Storb RF, Sauvage LR, Hammand WP, and Wu MHD. Enhanced endothelialization and microvessel formation in polyester graft seeded with CD34+ bone marrow cells. Blood 95: 581-585, 2000.
5. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, and Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333: 283-287, 1995.
6. Carmeliet P, Ferreira V, and Breier G. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
7. Chauhan A, More RS, Mullins PA, Taylor G, Petch MC, and Schofield PM. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 28: 1796-1804, 1996.
8. Cosentino F and Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32: S54-S61, 1998.
9. -/- mice. Circulation 99: 3188-3198, 1999.
10. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, and Bowen-Pope DF. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87: 728-730, 2000.
11. Pavidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J, Horwitz E, Vanin EF, and Nienhuis AW. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7: 2870-2879, 2001.
12. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, and Aeiher AM. HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the PI3 kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
13. Drexler H, Zeiher AM, Meinzer K, and Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by t-arginine. Lancet 338: 1546-1550, 1991.
14. Evans JT, Kelly PF, O'Neill E, and Garcia JV. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther 10: 1479-1489, 1999.
15. Ferrara N, Carver-Moore K, and Chen H. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
16. Flamme I and Risau W. Induction of vasculogenesis and hemalopoiesis in vitro. Development 116: 435-439, 1992.
17. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendouhi M, Sidman RL, Wolfe JH, Kim SU, and Snyder EY. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16: 1033-1039, 1999.
18. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
19. Folkman J. Tumor angiogenesis. In: Cancer Medicine, edited by Holland JF, Frei E III, Bast RC Jr, Kute DW, Morton DL, and Weichselbaum RR. Philadelphia. PA: Lea & Febiger, 1993, p. 153-170.
20. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, and Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000.
21. Gerhard M, Roddy MA, Creager SJ, and Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27: 849-853, 1996.
22. + endothelial precursor cells. Circ Res 88: 167-174, 2001.
23. Gunsiiius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockha G, Gabl C, Dirnhofer S, Clausen J, and Gastl G. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355: 1688-1691, 2000.
24. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, and Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193: 1005-1014, 2001.
25. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, and Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125: 1457-1468, 1998.
26. Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, and Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33: 1362-1368, 2002.
27. His W. Leoithoblast und Angioblast der Wirbelthiere. Abhandl K S Ges Wiss Math Phys 22: 171-328, 1900.
28. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, and Symes JF. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28: 964-975, 1998.
29. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, and Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738, 2002.
30. Johnstone MD, Creager SJ, Scales KM, Cusco JA, Lee BK, and Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516, 1993.
31. Kalka C, Masuda H, Gordon R, Silver M, and Asahara T. Age dependent response in mobilization of endothelial progenitor cells (EPC) to VEGF gene therapy in human subjects. Circulation 100: 1-40, 1999.
32. Kalka C, Masuda H, Takahashi T, Kalka-Moll W, Silver M, Kearney M, Li T, Isner J, and Asahara T. Transplantation of ex-vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
33. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, and Mayer JE Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040, 2001.
34. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001.
35. Kessinger A and Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211-213, 1991.
36. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkoff D, Wang J, Homma S, Edwards NM, and Itescu S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
37. Kureishi Y, Luo Z, and Shiojima I. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010, 2000.
38. Lammert E, Cleaver O, and Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 294: 564-507, 2001.
39. Lin Y, Weisdorf D, Solovey A, and Hehhel R. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
40. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, and Marsden CD. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577, 1990.
41. Llevadot J, Murasawa S, Kureishi Y, Uehida S, Masuda H, Kawamoto A, Walsh K, Isner JM, and Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405, 2001.
42. Luscher TF and Tshuci MR. Endothelial dysfunction in coronary artery disease. Annu Rev Med 44: 395-418, 1993.
43. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadhurn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, and Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201, 2001.
44. Matsumoto K, Yoshitomi H, Rossant J, and Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294: 559-563, 2001.
45. Murayama T, Tepper OM, Silver M, Ma H, Losordo D, Isner JM, Asahara T, and Kalka C. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30: 967-972, 2002.
46. Pardanaud L, Altman C, Kilos P, and Dieterien-Lievre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105: 473-485, 1989.
47. Peichev M, Naiyer AJ, Pereira D, Ahu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, and Moore MAS. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000.
48. Poole TJ, Finkelstein EB, and Cox CM. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220: 1-17, 2001.
49. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, and Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346, 2002.
50. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, and Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625, 2001.
51. Risau W. Differentiation of endothelium. FASEB J 9: 926-933, 1995.
52. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, and Doetschman T. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 102: 471-478, 1988.
53. Rivard A, Asahara T, Takahashi T, Chen D, and Isner JM. Contribution of endothelial progenitor cells to neovascularization (vasculogenesis) is impaired with aging. Circulation 98: 1-39, 1998.
54. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, and Isner JM. Age-dependent impairment of angiogenesis. Circulation 99: 111-120, 1999.
55. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, and Isner JM. Rescue of diabetes related impairment of angiogenesis by iniramuscalar gene therapy with adeno-VEGF. Am J Pathol 154: 355-364, 1999.
56. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, and Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106: 571-578, 2000.
57. Shalaby F, Rossant J, Yamaguchi T, Gertsenstein M, Wu X, Breitman M, and Schuh A. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66, 1995.
58. Sheridan WP, Begley CG, and Juttener C. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339: 640-644, 1992.
59. Shi Q, Rafii S, Wu MD, Wijelath E, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage L, Moore M, Storb R, and Hammond W. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998.
60. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, and Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2779, 2001.
61. Shpall EJ, Jones RB, and Bearman SI. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy. J Clin Oncol 12: 28-36, 1994.
62. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo B, Sudano I, and Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91: 1981-1987, 1995.
63. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner J, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 4: 434-438, 1999.
64. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, and Gurtner GC. Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
65. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, and Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98: 899-905, 1996.
66. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, and Isner JM. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96: 2667-2674, 1997.
67. Vasa M, Breitschopf K, Zeiher AM, and Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 87: 540-542, 2000.
68. Weiss M and Orkin SH. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest 97: 591-595, 1996.
69. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, and Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408: 92-96, 2000.
70. Zhang ZG, Zhang L, Jiang Q, and Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90: 284-288, 2002.